John C. Ayres serves as Executive at ARATANA THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, John C. Ayres has executed 3 insider transactions totaling $13.1K, demonstrating a bearish approach to their equity position. Their most recent transaction on Jul 18, 2019 involved selling 129,889 shares valued at $0.
John C. Ayres currently holds 129,889 shares of ARATANA THERAPEUTICS, INC. (PETX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. Ayres has been a net seller of PETX stock. They have purchased $0 and sold $13.1K worth of shares.
John C. Ayres's most recent insider trade was on Jul 18, 2019, when they sold 129,889 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.19 |
| Discretionary |
| Jan 24, 2019 | PETX | $0 | Award | 34,923 | $N/A | Discretionary |